BRAINLIFE.ORG





Topics


Gliomas | Etiopathogenesis | Cancer stem cells






Home > Publications > Topics > Gliomas > Etiopathogenesis > Cancer stem cells






Pećina-Šlaus N, Hrašćan R.
Glioma Stem Cells-Features for New Therapy Design.
Cancers (Basel). 2024 Apr 19;16(8):1557. doi: 10.3390/cancers16081557. PMID: 38672638. Review. ˍ




Agosti E, Zeppieri M, Ghidoni M, Ius T, Tel A, Fontanella MM, Panciani PP.
Role of glioma stem cells in promoting tumor chemo- and radioresistance: A systematic review of potential targeted treatments.
World J Stem Cells. 2024 May 26;16(5):604-614. doi: 10.4252/wjsc.v16.i5.604. PMID: 38817336. Review. ˍ




Selvaraj S, Srinivas BH, Verma SK, Ms G.
Significance of Nestin and CD133 as cancer stem cell markers in diffuse glioma and association with p53 expression and IDH status.
Int J Clin Exp Pathol. 2024 Jul 15;17(7):208-218. doi: 10.62347/YXVS6225. PMID: 39114503. Observational study. ˍ




Agosti E, Antonietti S, Ius T, Fontanella MM, Zeppieri M, Panciani PP.
Glioma Stem Cells as Promoter of Glioma Progression: A Systematic Review of Molecular Pathways and Targeted Therapies.
Int J Mol Sci. 2024 Jul 22;25(14):7979. doi: 10.3390/ijms25147979. PMID: 39063221. Review. ˍ